vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.
Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -32.1%, a 36.7% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-17.4M). Over the past eight quarters, Lifeway Foods, Inc.'s revenue compounded faster (11.4% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
LFCR vs LWAY — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $55.4M |
| Net Profit | $-10.0M | $2.5M |
| Gross Margin | 25.0% | 27.8% |
| Operating Margin | -9.9% | 6.8% |
| Net Margin | -32.1% | 4.6% |
| Revenue YoY | -4.5% | 18.0% |
| Net Profit YoY | -52.0% | 1688.1% |
| EPS (diluted) | $-0.29 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.4M | ||
| Q3 25 | $31.1M | $57.1M | ||
| Q2 25 | — | $53.9M | ||
| Q1 25 | $35.2M | $46.1M | ||
| Q4 24 | $32.6M | $46.9M | ||
| Q3 24 | $24.7M | $46.1M | ||
| Q2 24 | — | $49.2M | ||
| Q1 24 | $35.7M | $44.6M |
| Q4 25 | — | $2.5M | ||
| Q3 25 | $-10.0M | $3.5M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | $-14.8M | $3.5M | ||
| Q4 24 | $-6.6M | $-160.0K | ||
| Q3 24 | $-16.2M | $3.0M | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | $15.6M | $2.4M |
| Q4 25 | — | 27.8% | ||
| Q3 25 | 25.0% | 28.7% | ||
| Q2 25 | — | 28.6% | ||
| Q1 25 | 28.0% | 23.9% | ||
| Q4 24 | 34.0% | 25.3% | ||
| Q3 24 | 21.8% | 25.7% | ||
| Q2 24 | — | 27.0% | ||
| Q1 24 | 33.3% | 25.8% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | -9.9% | 8.8% | ||
| Q2 25 | — | 10.8% | ||
| Q1 25 | -25.7% | 3.4% | ||
| Q4 24 | -6.0% | 1.5% | ||
| Q3 24 | -46.9% | 9.1% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | -2.5% | 8.0% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | -32.1% | 6.2% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | -42.0% | 7.7% | ||
| Q4 24 | -20.2% | -0.3% | ||
| Q3 24 | -65.7% | 6.5% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | 43.8% | 5.4% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-0.29 | $0.23 | ||
| Q2 25 | — | $0.28 | ||
| Q1 25 | $-0.47 | $0.23 | ||
| Q4 24 | $-0.25 | $0.00 | ||
| Q3 24 | $-0.53 | $0.19 | ||
| Q2 24 | — | $0.25 | ||
| Q1 24 | $0.42 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $5.6M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $85.8M |
| Total Assets | $235.2M | $105.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | $18.9M | $23.0M | ||
| Q2 25 | — | $21.2M | ||
| Q1 25 | $5.4M | $19.4M | ||
| Q4 24 | $9.5M | $16.7M | ||
| Q3 24 | — | $20.6M | ||
| Q2 24 | — | $14.6M | ||
| Q1 24 | — | $12.0M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | $2.5M |
| Q4 25 | — | $85.8M | ||
| Q3 25 | $-10.5M | $82.8M | ||
| Q2 25 | — | $78.7M | ||
| Q1 25 | $2.2M | $74.2M | ||
| Q4 24 | $15.4M | $71.9M | ||
| Q3 24 | $-3.9M | $71.5M | ||
| Q2 24 | — | $68.0M | ||
| Q1 24 | $17.7M | $63.5M |
| Q4 25 | — | $105.6M | ||
| Q3 25 | $235.2M | $109.5M | ||
| Q2 25 | — | $98.3M | ||
| Q1 25 | $237.7M | $93.7M | ||
| Q4 24 | $255.4M | $90.5M | ||
| Q3 24 | $246.8M | $91.3M | ||
| Q2 24 | — | $84.9M | ||
| Q1 24 | $246.2M | $82.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $267.0K |
| Free Cash FlowOCF − Capex | $25.0K | $-17.4M |
| FCF MarginFCF / Revenue | 0.1% | -31.5% |
| Capex IntensityCapex / Revenue | 5.6% | 31.9% |
| Cash ConversionOCF / Net Profit | — | 0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-16.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $267.0K | ||
| Q3 25 | $1.8M | $6.9M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | $1.2M | $-150.0K | ||
| Q4 24 | $-6.1M | $-2.6M | ||
| Q3 24 | $-613.0K | $7.5M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | $-1.4M | $1.5M |
| Q4 25 | — | $-17.4M | ||
| Q3 25 | $25.0K | $1.8M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | $-4.3M | $-2.4M | ||
| Q4 24 | $-8.6M | $-3.8M | ||
| Q3 24 | $-4.0M | $5.9M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-7.8M | $-923.0K |
| Q4 25 | — | -31.5% | ||
| Q3 25 | 0.1% | 3.1% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | -12.1% | -5.1% | ||
| Q4 24 | -26.3% | -8.2% | ||
| Q3 24 | -16.3% | 12.8% | ||
| Q2 24 | — | 10.4% | ||
| Q1 24 | -21.8% | -2.1% |
| Q4 25 | — | 31.9% | ||
| Q3 25 | 5.6% | 9.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | 15.5% | 4.8% | ||
| Q4 24 | 7.5% | 2.7% | ||
| Q3 24 | 13.9% | 3.3% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | 17.8% | 5.5% |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 1.96× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | -0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.50× | ||
| Q2 24 | — | 1.73× | ||
| Q1 24 | -0.09× | 0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
